Influence of OATPs on Hepatic Disposition of Erlotinib Measured With Positron Emission Tomography

Martin Bauer; Akihiro Matsuda; Beatrix Wulkersdorfer; Cecile Philippe; Alexander Traxl; Csilla O¨zvegy-Laczka; Johann Stanek; Lukas Nics; Eva Maria Klebermass; Stefan Poschner; Walter Jäger; Izabel Patik; E´va Bakos; Gergely Szakács; Wolfgang Wadsak; Marcus Hacker; Markus Zeitlinger; Oliver Langer

doi:10.1002/cpt.888

Influence of OATPs on Hepatic Disposition of Erlotinib Measured With Positron Emission Tomography

Martin Bauer, Akihiro Matsuda, Beatrix Wulkersdorfer, Cecile Philippe, Alexander Traxl, Csilla O¨zvegy-Laczka, Johann Stanek, Lukas Nics, Eva Maria Klebermass, Stefan Poschner, Walter Jäger, Izabel Patik, E´va Bakos, Gergely Szakács, Wolfgang Wadsak, Marcus Hacker, Markus Zeitlinger, Oliver Langer

Publications: Contribution to journal › Article › Peer Reviewed

Original language	English
Pages (from-to)	139-147
Number of pages	9
Journal	Clinical Pharmacology and Therapeutics
Volume	104
Issue number	1
Early online date	3 Nov 2017
DOIs	https://doi.org/10.1002/cpt.888
Publication status	Published - Jul 2018

Austrian Fields of Science 2012

301205 Pharmacokinetics

Keywords

DRUG-DRUG INTERACTIONS
TRANSPORTING POLYPEPTIDES OATPS
CANCER RESISTANCE PROTEIN
HEPATOBILIARY TRANSPORT
MEMBRANE TRANSPORTERS
TYROSINE KINASE
PET
ROSUVASTATIN
EXPRESSION
INHIBITORS

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/cpt.888Licence: CC BY-NC 4.0

Cite this

Bauer, M., Matsuda, A., Wulkersdorfer, B., Philippe, C., Traxl, A., O¨zvegy-Laczka, C., Stanek, J., Nics, L., Klebermass, E. M., Poschner, S., Jäger, W., Patik, I., Bakos, E., Szakács, G., Wadsak, W., Hacker, M., Zeitlinger, M., & Langer, O. (2018). Influence of OATPs on Hepatic Disposition of Erlotinib Measured With Positron Emission Tomography. Clinical Pharmacology and Therapeutics, 104(1), 139-147. https://doi.org/10.1002/cpt.888

@article{0e67813d681a4bc0894469cc2dea94c7,

title = "Influence of OATPs on Hepatic Disposition of Erlotinib Measured With Positron Emission Tomography",

keywords = "DRUG-DRUG INTERACTIONS, TRANSPORTING POLYPEPTIDES OATPS, CANCER RESISTANCE PROTEIN, HEPATOBILIARY TRANSPORT, MEMBRANE TRANSPORTERS, TYROSINE KINASE, PET, ROSUVASTATIN, EXPRESSION, INHIBITORS",

author = "Martin Bauer and Akihiro Matsuda and Beatrix Wulkersdorfer and Cecile Philippe and Alexander Traxl and Csilla O¨zvegy-Laczka and Johann Stanek and Lukas Nics and Klebermass, {Eva Maria} and Stefan Poschner and Walter J{\"a}ger and Izabel Patik and E´va Bakos and Gergely Szak{\'a}cs and Wolfgang Wadsak and Marcus Hacker and Markus Zeitlinger and Oliver Langer",

note = "Publisher Copyright: {\textcopyright} 2017 The Authors Clinical Pharmacology & Therapeutics published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics",

year = "2018",

month = jul,

doi = "10.1002/cpt.888",

language = "English",

volume = "104",

pages = "139--147",

journal = "Clinical Pharmacology and Therapeutics",

issn = "0009-9236",

publisher = "PERGAMON-ELSEVIER SCIENCE LTD",

number = "1",

}

Bauer, M, Matsuda, A, Wulkersdorfer, B, Philippe, C, Traxl, A, O¨zvegy-Laczka, C, Stanek, J, Nics, L , Klebermass, EM , Poschner, S , Jäger, W, Patik, I, Bakos, E, Szakács, G, Wadsak, W, Hacker, M, Zeitlinger, M & Langer, O 2018, 'Influence of OATPs on Hepatic Disposition of Erlotinib Measured With Positron Emission Tomography', Clinical Pharmacology and Therapeutics, vol. 104, no. 1, pp. 139-147. https://doi.org/10.1002/cpt.888

TY - JOUR

T1 - Influence of OATPs on Hepatic Disposition of Erlotinib Measured With Positron Emission Tomography

AU - Bauer, Martin

AU - Matsuda, Akihiro

AU - Wulkersdorfer, Beatrix

AU - Philippe, Cecile

AU - Traxl, Alexander

AU - O¨zvegy-Laczka, Csilla

AU - Stanek, Johann

AU - Nics, Lukas

AU - Klebermass, Eva Maria

AU - Poschner, Stefan

AU - Jäger, Walter

AU - Patik, Izabel

AU - Bakos, E´va

AU - Szakács, Gergely

AU - Wadsak, Wolfgang

AU - Hacker, Marcus

AU - Zeitlinger, Markus

AU - Langer, Oliver

PY - 2018/7

Y1 - 2018/7

KW - DRUG-DRUG INTERACTIONS

KW - TRANSPORTING POLYPEPTIDES OATPS

KW - CANCER RESISTANCE PROTEIN

KW - HEPATOBILIARY TRANSPORT

KW - MEMBRANE TRANSPORTERS

KW - TYROSINE KINASE

KW - PET

KW - ROSUVASTATIN

KW - EXPRESSION

KW - INHIBITORS

UR - http://www.scopus.com/inward/record.url?scp=85032923595&partnerID=8YFLogxK

U2 - 10.1002/cpt.888

DO - 10.1002/cpt.888

M3 - Article

AN - SCOPUS:85032923595

SN - 0009-9236

VL - 104

SP - 139

EP - 147

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

IS - 1

ER -

Influence of OATPs on Hepatic Disposition of Erlotinib Measured With Positron Emission Tomography

Austrian Fields of Science 2012

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this